David Dodds
Präsident bei Sucampo Pharma Europe Ltd.
Aktive Positionen von David Dodds
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Präsident | 15.09.2009 | - |
| Corporate Officer/Principal | 07.08.2008 | 15.09.2009 |
Karriereverlauf von David Dodds
Ausbildung von David Dodds
| University of Sunderland | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
- Börse
- Insiders
- David Dodds
- Erfahrung
